Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01374919 · ClinicalTrials.gov registry record · NA
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
A NA study of Iron Deficiency Anemia, sponsored by Auerbach Hematology Oncology Associates P C.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01374919 is a NA study of Iron Deficiency Anemia that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 60 participants, below the 191-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01374919, a NA study of Iron Deficiency Anemia, has completed, sponsored by Auerbach Hematology Oncology Associates P C.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during immediate post dosing observation period. Assess additional safety profile and laboratory assessment at follow up visit and interim telephone follow up.
Conditions Studied
Interventions
- DRUG ferumoxytol
Study Locations (1)
Maryland
- Auerbach Hematology and Oncology - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01374919
The ClinicalTrials.gov registry entry for NCT01374919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 191-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (69% lower). The listed sponsor is Auerbach Hematology Oncology Associates P C, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iron Deficiency Anemia appearing as the primary indexed condition, and to 1 intervention - of which ferumoxytol is the first listed.
NCT01374919 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01374919 about?
NCT01374919 is a clinical study titled "Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia". The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during...
What is the current status of trial NCT01374919?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-06. Estimated completion is 2012-03.
What conditions does trial NCT01374919 study?
This clinical trial studies the following conditions: Iron Deficiency Anemia.
What interventions are being tested in trial NCT01374919?
The interventions under investigation include: ferumoxytol (DRUG).
Who is sponsoring clinical trial NCT01374919?
This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01374919 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron Deficiency Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia
COMPLETED · NA
-
Effect of Iron Supplements on the Growth of Enteric Pathogens
COMPLETED · NA
-
Improving the Iron Status of Athletes With Pre-, Pro- and Synbiotics
COMPLETED · NA
-
Pilot Study of the Effect of Iron Fortified Rice in Iron Deficient Anemic Women
COMPLETED · NA
-
EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia
COMPLETED · NA
-
Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.